Executives, investors, analysts and bankers are readying pitches, finalizing schedules and fine-tuning presentations for biotech’s biggest event of the year. The JP Morgan Healthcare Conference kicks off Monday in downtown San Francisco after a record-breaking year of deals and amid a swirl of industry pressures.
The conference, which takes place at the Westin St. Francis Hotel on the lip of Union Square, is the industry’s oldest and largest gathering of biotech companies and investors. More than 300 companies turn out. Each year, attendees search for vital signs on stock values and potential initial public offerings, and watch for new product debuts. This year, they say, they will also listen closely for emerging trends in other rapidly shifting sectors such as digital health and diagnostics.
But perhaps most importantly, the meeting is a catalyst for deals and partnerships to be forged or finalized.